centene chief medical officer centene chief medical officer

ST. LOUIS, April 20, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has named Anika Gardenhire RN, BSN, MMCI as its Chief Customer Experience Officer (CXO). Transforming the health of the community, one person at a time. corporate governance. Both individuals will report to Sarah London. Chirag Patel M.D., is an internal medicine and pulmonary/critical care medicine physician, at Centene. Centene.com uses cookies. Ken Yamaguchi, MD, MBA - LinkedIn Prior to that he served as CEO of UnitedHealth Care's Central Region, President of UnitedHeathcare lines of business and National Sales Officer. Mr. Layton received his bachelor's degree from the University of Georgia. CENTENE CORPORATION NAMES ANIKA GARDENHIRE CHIEF CUSTOMER EXPERIENCE OFFICER - Apr 20, 2023 ST. LOUIS, April 20, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has named . Centene Chief Medical Officer Salaries in the United States Centene.com uses cookies. Chief Customer Experience Officer. Ms. London began her healthcare career at Health Leads, a nationally-recognized social enterprise that partners with healthcare organizations to address social determinants of health by connecting patients to the community-based resources needed to support high-quality, cost-effective health outcomes. The appointments of Messrs. Fasola, Murray, Layton and Thomas to their new roles are effective today. Her focus has been advancing integrated, value-based care models through the development and application of data-driven insights and technology. He served as CEO of Secure Horizons, a division of UnitedHealth Group and the nation's largest Medicare Advantage insurer. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. Alice Hm Chen | Chief Health Officer | Centene Alice Hm Chen - Chief Health Officer - Centene Corporation - LinkedIn Mr. Murray received his bachelor's degree in accounting from the University of Dayton and is a certified public accountant. and Terms and Margaret-Mary Wilson MD, MBA, MRCP, FNMCP - Chief Medical Officer and Executive Vice President - UnitedHealth Group | LinkedIn Margaret-Mary Wilson MD, MBA, MRCP, FNMCP Chief Medical. Brent Layton, Senior Advisor to CEO, Centene Corporation. "I also want to thank Michael Neidorff, Centene's visionary leader for more than 25 years. Mr. Fasola holds a Bachelor of Science in Health Planning and Administration from Pennsylvania State University and was named an Alumni Fellow in 2010. Centene Corporation Announces Leadership Changes and Appointments for Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity, and delivery system transformation. Executive Leadership | Centene Corporation The health of individuals drives our focus on the environment, from 8 AM - 9 PM ET. In his role as President, Mr. Fasola brings more than three decades of successful leadership in the healthcare industry, including CEO roles at multiple health insurance companies. Ms. London previously served as Vice President of Client Services & Operations with Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Centene Board of Directors. Si continas recibiendo este mensaje, infrmanos del problema Si vous continuez voir ce James Richardson MD FACEP - Chief Medical Director - Centene - LinkedIn https://www.prnewswire.com/news-releases/centene-appoints-sarah-london-as-chief-executive-officer-301508299.html, Purchase Order "The healthcare landscape is rapidly changing, and Centene's mission to transform the health of our communities one member at a time has never been more relevant. Centene Corporation About Dr. Alice Hm Chen is chief health office for Centene, the largest Medicaid and Marketplace managed care organization in the U.S., where she is responsible for. All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Most COVID-19 vaccines require two injections; the first starts building protection and the second is given a few weeks later. Prior to Optum Ventures, Ms. London served as Chief Product Officer for Optum Analytics, the business unit responsible for driving strategy and commercialization of Optum's integrated data and analytics solutions into the provider, payer and life sciences markets. Q1 2023 Centene Corp Earnings Call - Yahoo Finance Centeneoffers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, our investments and the adequacy of our available cash resources. Ms. London has spent her career at the forefront of innovation in healthcare. Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. Aiutaci a proteggere Glassdoor dimostrando che sei una persona reale. This list of important factors is not intended to be exhaustive. This list of important factors is not intended to be exhaustive. Centene expects Medicare Advantage, Medicaid changes to dampen profits Alice H. Chen, MD, MPH, Chief Health Officer, Centene Corporation. Join to view profile . The appointments of Messrs. Fasola, Murray, Layton and Thomas to their new roles are effective today. ST. LOUIS, Dec. 14, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today leadership changes and senior management appointments to position the Company for its next stage of growth. message, please email Thats why it has been important for Wellcare to hold events in the community and partner with trusted community voices. Awards & Community Engagement In March 2023 , Fortune magazine named Centene as . Lamentamos Centene Corporation Names Anika Gardenhire Chief Customer Experience You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to:our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully;restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. Se continui a visualizzare Mr. Layton most recently served as President and Chief Operating Officer for Centene Corporation where he oversaw the company's healthcare offerings, including 30 State Medicaid Health plans, the nation's largest Exchange provider, Ambetter, and the WellCare brand of Medicare products, and was a member of the Office of the CEO. Our local approach allows us to help members access high-quality, culturally sensitive healthcare services. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity, and delivery system transformation. The health of individuals drives our focus on the environment, removing social barriers to health, and prioritizing responsible corporate governance. Equipped with deep experience in operations spanning a career of nearly three decades, Mr. Murray will be critical to Centene's efforts in value creation, quality, and core business operations. Additionally, the Company announced the appointment of Alice H. Chen, MD, MPH, as Chief Health Officer (CHO), effective January 1, 2023, and Brian LeClaire, MBA, PhD, as Chief Information Officer (CIO), effective December 5, 2022. Centene Corporation Names Anika Gardenhire Chief Customer Experience David P. Thomas, CEO, Markets and Medicaid, Centene Corporation. questo messaggio, invia un'email all'indirizzo She has a background in preventive medicine, with a medical degree from Texas A&Ms College of Medicine, and has experience in the public and private sectors experience that has been helpful during the pandemic as Wellcare has worked closely with local health departments to help encourage COVID-19 testing and vaccinations. 7555 E Osborn Road, Scottsdale 85251. As a practicing physician. She previously served as Deputy Secretary for Policy and Planning and Chief of Clinical Affairs for the . Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. Dr. Yamaguchi received a dose of the vaccine at Barnes-Jewish Hospital in St. Louis, Missouri (pictured). It gives her an opportunity to speak to the Hispanic community about a vital issue, directly discussing her familys own experiences. Murray also served as Executive Vice President and Chief Operating Officer for Humana and held other significant leadership roles over a career spanning nearly three decades. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de Centene said it net income increased 33% year-over-year, to $1.13 billion, or $2.11 earnings per share, on revenues of $38.8 billion, driven by increased exchange revenue and lower medical expenses. Chief Health Officer. In her new . Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, after the date hereof. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's . om ons te informeren over dit probleem. Dave Thomas, currently EVP, Markets, will become CEO of Markets and Medicaid, reporting into Mr. Fasola. Transforming the health of the community, one person at a time. Brent Layton, Senior Advisor to CEO, Centene Corporation. Mr. Thomas received a bachelor's degree in Sociology from the University at Albany and a Master of Business Administration from the Zicklin School of Business at Baruch College in Manhattan. I'm thrilled to be part of this management team, and I firmly believe in the potential of this Company to continue its remarkable history of accomplishment within the healthcare industry.". Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, afterthe date hereof. When were able to bring resources to bear information and volunteers and bring them right into a neighborhood, we see people who come out who may at first just be curious, and then theyre able to communicate in the language they feel most comfortable with, and the next thing you know, theyre bringing along their families and friends, Dr. Guerra said. The CDC's recommendations for individuals eligible for the initial phases of COVID-19 vaccination are below: The phased approach addresses and prioritizes vaccination for healthcare workers, people in long-term care facilities, and certain groups of essential workers and first responders. Our medical directors play vital roles in everything from case review to acting as spokespersons advocating for healthy behaviors to shape and promote initiatives that improve the health of millions of members. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, after the date hereof. Over the next year, Mr. Layton will continue to play a pivotal role in developing and expanding key strategic partnerships for Centene and driving the Company's business development strategy. When typing in this field, a list of search results will appear and be automatically updated as you type. Both individuals will report to Sarah London. The Company also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. "In her new role, Anika will serve as the voice of Centene's customers, which is . removing social barriers to health, and prioritizing responsible Previously, he was President and COO for Magellan Health where he oversaw the Magellan Behavioral and Specialty Health and Magellan Complete Care business segments. Her strategic thinking, fresh perspective and diverse experience make her the natural leader to harness the potential of Centene," said James Dallas, Acting Chairman of Centene. Equipped with deep experience in operations spanning a career of nearly three decades, Mr. Murray will be critical to Centene's efforts in value creation, quality, and core business operations. CENTENE CORPORATION REPORTS FIRST QUARTER 2023 RESULTS - Yahoo Finance Purchase Order Centene Corporation 770 Forsyth Blvd. Margaret-Mary Wilson MD, MBA, MRCP, FNMCP - LinkedIn Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. los inconvenientes que esto te pueda causar. Since joining Centene in 2006, he has overseen the development and implementation of new health plans in more than 25 states, provided strategic guidance to state governments to help them develop effective Medicaid solutions, and developed new business contracting with providers and health systems where he led the company's effort in value-based purchasing. para nos informar sobre o problema. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Prior to that, he was Chairman, President, and CEO of HealthMarkets, Inc., one of the largest health insurance agencies and supplemental insurance companies in the U.S. HealthMarkets was acquired by UnitedHealth Group in 2019. Brent Layton becomes Senior Advisor to the CEO, Dave Thomas becomes Chief Executive Officer of Markets and Medicaid, Additionally, Company appoints Alice H. Chen, MD, MPH as Chief Health Officer and Brian LeClaire, MBA, PhD, as Chief Information Officer. enviando un correo electrnico a Jim Murray most recently served as Centene's Chief Transformation Officer, where he led Centene's Value Creation Office and its Behavior Health business and was a member of the office of the CEO. Ken Fasola, currently Executive Vice President (EVP) of Health Care Enterprises, will become President of Centene, continuing to report to Sarah London. Terms & Conditions. Centene focuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. Wir entschuldigen uns fr die Umstnde. COVID-19 Vaccination: Q&A with Centene's Chief Medical Officer, most up-to-date information on the COVID-19 vaccine. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well. As CIO, Mr. LeClaire will be responsible for Centene's information technology strategy, ensuring its alignment with the Company's business strategy, and delivering secure, differentiated technology-enabled experiences to members. Murray also served as Executive Vice President and Chief Operating Officer for Humana and held other significant leadership roles over a career spanning nearly three decades. Prior to his roles at Magellan, Mr. Murray served as President of PrimeWest Health, a Dallas-based company which supports physician shift to value-based care and Chief Executive Officer of LifeCare HealthPartners, a Dallas-based hospital system. Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. Shes appeared on Spanish-language radio stations to promote COVID-19 vaccines, and Wellcare has been holding events targeting the Hispanic community. las molestias. I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders.". uctuations in medical . Experience Chief Medical officer at Centene, Nevada Centene (Silver Summit and Ambetter) Jan 2022 - Present1 year 4 months Nevada, United States Vice President for Quality and Utilization. Mr. Murray received his bachelor's degree in accounting from the University of Dayton and is a certified public accountant. naar Established physician leader, board-certified emergency medicine physician for over 20 years, and Fellow in the American College of Emergency Physicians (FACEP), with valuable management experience. At Humana Mr. Fasola was the COO of Market Operations and formerly a member of the Office of the Chairman, a role he assumed after thirteen years leading various divisions within the company. He joined Centene through the acquisition of Magellan Health Inc (MGLN) where he served as CEO and a member of the Board of Directors. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the ongoing impact of COVID-19; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the acquisition of Magellan Health, Inc. (the Magellan Acquisition); the possibility that the expected synergies and value creation from the Magellan Acquisition or the acquisition of WellCare Health Plans, Inc. (the WellCare Acquisition) (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition; unexpected costs, or similar risks, from other acquisitions or dispositions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; the risk that the closing conditions, including applicable regulatory approvals, for the pending disposition of Magellan Specialty Health may be delayed or not obtained; impairments to real estate, investments, goodwill and intangible assets; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the current administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price and accretion for acquisitions or dispositions; restrictions and limitations in connection with our indebtedness; the availability of debt and equity financing on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.